The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108   20,284,524 846,953 SH   SOLE   846,953 0 0
AFTERNEXT HEALTHTECH ACQUISITION CORP *W EXP 99/99/999 G01109126   31,753 366,666 SH   SOLE   366,666 0 0
AMICUS THERAPEUTICS INC COM 03152W109   16,651,734 1,325,775 SH   SOLE   1,325,775 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106   22,017,959 241,690 SH   SOLE   241,690 0 0
ARES ACQUISITION CORP *W EXP 02/02/202 G33032122   403,765 504,706 SH   SOLE   504,706 0 0
ARVINAS INC COM 04335A105   10,213,430 411,500 SH   SOLE   411,500 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101   12,474,651 139,772 SH   SOLE   139,772 0 0
BAUSCH HEALTH COS INC COM 071734107   9,320,000 1,165,000 SH   SOLE   1,165,000 0 0
BILANDER ACQUISITION CORP *W EXP 05/19/202 09001T114   9,334 183,749 SH   SOLE   183,749 0 0
BRIDGETOWN HOLDINGS LTD *W EXP 09/30/202 G1355U121   221,960 895,000 SH   SOLE   895,000 0 0
CEREVEL THERAPEUTICS HLDNG I COM 15678U128   15,658,006 492,545 SH   SOLE   492,545 0 0
CHURCHILL CAPITAL CORP V *W EXP 10/29/202 17144T115   110,221 612,000 SH   SOLE   612,000 0 0
CHURCHILL CAPITAL CORP VI *W EXP 02/17/202 17143W119   97,200 540,000 SH   SOLE   540,000 0 0
CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 17144M110   76,720 548,000 SH   SOLE   548,000 0 0
CLARIVATE PLC ORD SHS G21810109   11,887,779 1,247,406 SH   SOLE   1,247,406 0 0
COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 G2476C123   68,434 459,906 SH   SOLE   459,906 0 0
CONCORD ACQUISITION CORP II *W EXP 99/99/999 20607U116   16,333 408,333 SH   SOLE   408,333 0 0
CONYERS PARK III ACQUISITION CORP *W EXP 08/12/202 21289P110   28,583 571,666 SH   SOLE   571,666 0 0
CORSAIR PARTNERING CORP *W EXP 07/06/202 G2540H116   0 334,666 SH   SOLE   334,666 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107   14,371,437 797,527 SH   SOLE   797,527 0 0
CYTOKINETICS INC COM NEW 23282W605   12,039,814 369,093 SH   SOLE   369,093 0 0
FIRST LIGHT ACQUISITION GROUP INC *W EXP 03/14/202 320703119   85,176 655,200 SH   SOLE   655,200 0 0
GALAPAGOS NV SPON ADR 36315X101   16,542,887 406,859 SH   SOLE   406,859 0 0
HOME PLATE ACQUISITION CORP *W EXP 09/30/202 43734R111   14,697 690,000 SH   SOLE   690,000 0 0
MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 56608A113   41,307 735,000 SH   SOLE   735,000 0 0
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104   15,402,000 302,000 SH   SOLE   302,000 0 0
MORPHIC HOLDING INC COM 61775R105   16,485,585 287,556 SH   SOLE   287,556 0 0
PROTHENA CORP PLC SHS G72800108   21,665,244 317,300 SH   SOLE   317,300 0 0
RELAY THERAPEUTICS INC COM 75943R102   8,811,719 701,570 SH   SOLE   701,570 0 0
ROSS ACQUISITION CORP II *W EXP 02/01/202 G7641C114   74,435 439,666 SH   SOLE   439,666 0 0
SAGE THERAPEUTICS INC COM 78667J108   16,822,110 357,765 SH   SOLE   357,765 0 0
SAREPTA THERAPEUTICS INC COM 803607100   14,367,336 125,457 SH   SOLE   125,457 0 0
SOLID BIOSCIENCES INC COM NEW 83422E204   5,036,955 961,251 SH   SOLE   961,251 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107   15,958,226 608,628 SH   SOLE   608,628 0 0
SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 G63836111   48,020 490,000 SH   SOLE   490,000 0 0
TRAVERE THERAPEUTICS INC COM 89422G107   11,700,035 761,721 SH   SOLE   761,721 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117   23,030 489,999 SH   SOLE   489,999 0 0